SDRF-Proteomics

oncology-metadata

v1.0.0 sample

SDRF template for cancer/oncology study samples with tumor staging, grading, and clinical outcome metadata. Extends clinical-metadata with oncology-specific columns. Combine with organism template (human, vertebrates) and technology template (ms-proteomics, affinity-proteomics).

Key Guidance

The oncology-metadata template extends clinical-metadata with cancer-specific staging,

grading, and outcome columns. It supports multiple standardized staging systems.

Key guidance:

  • characteristics[disease staging]: General disease stage (stage I-IV). Use NCIT or

EFO terms.

  • characteristics[tumor stage]: TNM notation (e.g., T2N1M0). Prefix with p for

pathological or c for clinical staging.

  • Specialized staging systems (use the appropriate column for the cancer type):
  • characteristics[dukes stage]: Colorectal cancer (A, B, C, D).
  • characteristics[ann arbor stage]: Lymphoma (I-IV with A/B/E/S suffix).
  • characteristics[gleason score]: Prostate cancer (sum or components: 3+4, 4+3).
  • characteristics[weiss grade]: Adrenal cortical carcinoma (low, high).
  • characteristics[histologic subtype]: Molecular/histologic classification (luminal A,

triple-negative, adenocarcinoma, squamous cell carcinoma).

  • characteristics[survival time] / characteristics[last follow up]: Time with unit

for clinical outcome tracking.

  • characteristics[metastasis site] / characteristics[biopsy site]: UBERON/BTO terms

for anatomical locations.

Inherits all clinical-metadata columns (compound, dose, treatment, demographics).

Inheritance

base sample-metadata clinical-metadata oncology-metadata

Columns

17 own + 39 inherited = 56 total · click a row for details
Column Requirement Source Description
characteristics[disease staging] optional oncology-metadata Disease progression stage (stage I-IV, chronic phase, end stage)
Disease progression stage (stage I-IV, chronic phase, end stage)
allows N/A allows not available
ontology — ontologies: ncit, efo
Disease staging should be a valid NCIT or EFO term
stage I, stage II, stage III, stage IV, chronic phase, end stage
characteristics[tumor grading] optional oncology-metadata Histological tumor grade (describes how abnormal cells look)
Histological tumor grade (describes how abnormal cells look)
allows N/A allows not available
ontology — ontologies: ncit
Tumor grading should be a valid NCIT term
grade 1, grade 2, grade 3, grade 4, high grade, low grade
characteristics[tumor stage] optional oncology-metadata TNM staging notation (describes extent of cancer spread)
TNM staging notation (describes extent of cancer spread)
allows N/A allows not available
ontology — ontologies: ncit
Tumor stage in TNM notation
T2N1M0, T3N0M0, T1N0M0, T4N2M1
characteristics[tumor size] optional oncology-metadata Tumor size measurement
Tumor size measurement
allows N/A allows not available
number_with_unit
Tumor size with unit
2.5 cm, 15 mm, 0.8 cm
characteristics[tumor mass] optional oncology-metadata Tumor mass/weight measurement
Tumor mass/weight measurement
allows N/A allows not available
number_with_unit
Tumor mass with unit
15 g, 250 mg
characteristics[histologic subtype] optional oncology-metadata Cancer molecular or histologic subtype
Cancer molecular or histologic subtype
allows N/A allows not available
ontology — ontologies: ncit
Histologic subtype should be a valid NCIT term
luminal A, luminal B, HER2-enriched, triple-negative, adenocarcinoma, squamous cell carcinoma
characteristics[metastasis site] optional oncology-metadata Location where cancer has spread from primary site
Location where cancer has spread from primary site
allows N/A allows not available
ontology — ontologies: uberon, bto
Metastasis site should be a valid UBERON or BTO term
liver, lung, bone, brain
characteristics[biopsy site] optional oncology-metadata Specific anatomical location of biopsy
Specific anatomical location of biopsy
allows N/A allows not available
ontology — ontologies: uberon, bto
Biopsy site should be a valid UBERON or BTO term
breast, colon, prostate, lung
characteristics[clinical data] optional oncology-metadata Free-text clinical details (receptor status, treatment history, surgical details)
Free-text clinical details (receptor status, treatment history, surgical details)
allows N/A allows not available
pattern — pattern: ^.+$
Free-text clinical data
ER+/PR+/HER2-, prior chemotherapy with doxorubicin, surgical resection performed
characteristics[clinical history] optional oncology-metadata Relevant medical history information for the patient
Relevant medical history information for the patient
allows N/A allows not available
pattern — pattern: ^.+$
Free-text clinical history
family history of breast cancer, previous radiation therapy, no significant medical history
characteristics[survival time] optional oncology-metadata Patient survival time for survival analysis studies
Patient survival time for survival analysis studies
allows N/A allows not available
number_with_unit
Survival time with unit
24 month, 3 year, 180 day
characteristics[last follow up] optional oncology-metadata Time of last clinical follow-up for longitudinal studies
Time of last clinical follow-up for longitudinal studies
allows N/A allows not available
number_with_unit
Last follow-up time with unit
36 month, 5 year, 365 day
characteristics[mitotic rate] optional oncology-metadata Number of mitoses per high-power field (indicator of tumor proliferation)
Number of mitoses per high-power field (indicator of tumor proliferation)
allows N/A allows not available
pattern — pattern: ^[\d]+(/\d+\s*HPF)?$
Mitotic rate as count or count per HPF
5, 12/10 HPF, 3/10 HPF
characteristics[dukes stage] optional oncology-metadata Dukes staging for colorectal cancer (A, B, C, D)
Dukes staging for colorectal cancer (A, B, C, D)
allows N/A allows not available
values — values: A, B, C, D
Dukes stage (A-D)
characteristics[ann arbor stage] optional oncology-metadata Ann Arbor staging for lymphoma (I, II, III, IV with optional A/B suffix)
Ann Arbor staging for lymphoma (I, II, III, IV with optional A/B suffix)
allows N/A allows not available
pattern — pattern: ^(I|II|III|IV)[AB]?[ES]?$
Ann Arbor stage (I-IV with optional A/B suffix for symptoms, E for extranodal, S for spleen)
IA, IIB, IIIA, IVB, IIE
characteristics[gleason score] optional oncology-metadata Gleason score for prostate cancer grading (sum of two pattern grades, range 2-10)
Gleason score for prostate cancer grading (sum of two pattern grades, range 2-10)
allows N/A allows not available
pattern — pattern: ^\d+(\+\d+)?$
Gleason score as sum (e.g., 7) or component pattern (e.g., 3+4)
7, 3+4, 4+3, 9, 5+4
characteristics[weiss grade] optional oncology-metadata Weiss scoring system for adrenal cortical carcinoma (low or high)
Weiss scoring system for adrenal cortical carcinoma (low or high)
allows N/A allows not available
values — values: low, high
Weiss grade (low or high)

Contributors